Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma
β Scribed by Zia, M I; Forsyth, P; Chaudhry, A; Russell, J; Stewart, D A
- Book ID
- 110013447
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 121 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Highβdose chemotherapy (HDCT) with autologous stem cell rescue (ASCR) has been reported to be effective in treating children with recurrent central nervous system (CNS) malignancies. ## METHODS. To evaluate the efficacy and toxicities of HDCT and ASCR, the medical reco
## Abstract ## BACKGROUND The objective of the current study was to determine the outcome of children with local recurrence or progression of medulloblastoma in patients who received highβdose chemotherapy (HDC) and posterior fossa (PF) irradiation. ## METHODS HDC consisted in busulfan at a dose